OCULAR PHARMACOLOGY.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
OBJECTIVE: To analyze different techniques of measuring accommodation after implantation of a new accommodative posterior chamber intraocular lens (PCIOL). METHODS: In this comparative, nonrandomized interventional study, we analyzed 15 eyes of 15 patients (aged 44-84 years) at 6 months after cataract surgery and PCIOL implantation (Akkommodative 1CU; HumanOptics AG, Erlangen, Germany) and compared these results with those of an age-matched control group (n = 15). We used the following methods to measure accommodation: dynamic measurement with objective (videorefractometry [PowerRefractor; PlusOptix, Erlangen] and streak retinoscopy) and subjective (subjective near point [push-up test and accommodometer] and defocusing) techniques, as well as static measurement of the change in anterior chamber depth (ACD) using the IOLMaster (Zeiss, Jena, Germany) after pharmacological stimulation using 2% pilocarpine eye drops. MAIN OUTCOME MEASURES: Theoretical accommodation calculated from the forward shift of the lens optics (decrease of ACD) using paraxial geometrical optics and measured accommodation amplitude. RESULTS: Accommodation amplitude (mean +/- SD; range; median) results after 6 months in the study and control groups were as follows: 1.00 +/- 0.44; 0.75-2.13; 1 diopter (D); and 0.35 +/- 0.26; 0.10-0.65; 0.25 D, respectively, using the PowerRefractor; 0.99 +/- 0.48; 0.13-2.00; 0.88 D; and 0.24 +/- 0.21; -0.13-0.75; 0.25 D, respectively, using retinoscopy; 1.6 +/- 0.55; 0.50-2.56; 1.7 D; and 0.42 +/- 0.25; 0.00-0.75; 0.50 D, respectively, using subjective near point; and 1.46 +/- 0.53; 1.00-2.50; 1.75 D; and 0.55 +/- 0.33; 0.25-0.87; 0.50 D, respectively, using defocusing. Anterior chamber depth decreased in the study and control groups as follows: 0.78 +/- 0.12; 0.49-1.91; 0.65 mm; and 0.16 +/- 0.09; 0.00-0.34; 0.18 mm, respectively, after applying 2% pilocarpine eyedrops, indicating an accommodation of 1.16 +/- 0.22; 0.72-1.88; 1.05 D vs 0.22 +/- 0.13; 0.00-0.47; 0.23 D (P =.001). CONCLUSIONS: Accommodation after implantation of a presumably accommodative PCIOL can be measured with clinical methods or derived from the biometric data of the eye and the measured ACD decrease using geometrical optics. For clinical purposes, pseudophakic accommodation should be assessed with a variety of different techniques, including subjective and objective measurements. The theoretical approach using geometrical optics may be an additional indicator for the accommodative response in patients with pseudophakic eyes and may allow a subdivision of the measured accommodation into true pseudophakic accommodation and pseudoaccommodation.
OBJECTIVES: To compare ocular biometry of the contralateral eyes of individuals seen with acute angle closure (AAC) with eyes of population-based control subjects, and to assess novel provocative tests to study the mechanism of AAC. DESIGN: Prospective case-control study. PARTICIPANTS: Chinese persons seen as incident cases of AAC and Chinese population-based controls. METHODS: Slitlamp assessment, ultrasonographic biomicroscopy, Scheimpflug photography, and provocative testing were performed. MAIN OUTCOME MEASURES: Ocular biometric parameters including anterior chamber depth, limbal anterior chamber depth, axial length, lens thickness, and radius of corneal curvature were obtained. Ultrasonographic biomicroscopy parameters that include the angle-opening distance at 500 micro m and the angle-recess area were noted. Scheimpflug photography produced a single measure of angle width. RESULTS: Contralateral eyes of cases of AAC had shorter axial lengths, shallower anterior chamber depths, thicker lenses, and steeper radii of corneal curvature (P<.01). After adjusting for age and sex, cases had a mean adjusted axial length that was 1.2 mm shorter, an optical anterior chamber depth that was 0.63 mm shallower (24% shallower than controls), and lenses that were, on average, 0.35 mm thicker (P<.01). Furthermore, using multiple logistic regression to adjust for age and sex, patients with primary angle-closure glaucoma were 19 times as likely to have a shallower limbal anterior chamber depth (25%; 95% confidence interval, 8.3-45.2). Adjusting for age and sex, the mean angle-opening distance at 500 microm was 0.14 U less for cases, with a mean of 0.26 U in controls, making the angle-opening distance at 500 microm, on average, 54% less among cases. Scheimpflug photographs revealed an adjusted angle width of 21.6 degrees for controls and 15.1 degrees for cases (P<.05). Dynamic testing showed that the angle of control eyes tended to shallow less when going from light to dark and tended to open more when given 1 drop of pilocarpine hydrochloride. CONCLUSIONS: Contralateral eyes of individuals having an AAC attack tend to be shorter and have more crowded anterior segments than those of healthy controls. These static measures of ocular biometry indicate why some individuals are predisposed to AAC. Dynamic measures of the response to luminance changes and pilocarpine therapy indicate that differential reactions to these stimuli are also associated with an AAC attack.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.